OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 424

Showing 1-25 of 424 citing articles:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 985

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, et al.
Science (2021) Vol. 374, Iss. 6572
Open Access | Times Cited: 804

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 210-216
Open Access | Times Cited: 746

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Rishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 662

Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 322

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
Fatima Amanat, Mahima Thapa, Tinting Lei, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3936-3948.e10
Open Access | Times Cited: 280

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 271

SARS-CoV-2 spreads through cell-to-cell transmission
Cong Zeng, John P. Evans, Tiffany King, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 203

Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R. Goel, Mark M. Painter, Kendall A. Lundgreen, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1875-1887.e8
Open Access | Times Cited: 185

The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 164

COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review
Christopher Peterson, Benjamin Lee, Kenneth Nugent
Vaccines (2022) Vol. 10, Iss. 6, pp. 948-948
Open Access | Times Cited: 156

The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 147

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 145

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
Jonathan Lopez, Marine Mommert, William Mouton, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 10
Open Access | Times Cited: 120

Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells
Rémi Planès, Miriam Pinilla, Karin Santoni, et al.
Molecular Cell (2022) Vol. 82, Iss. 13, pp. 2385-2400.e9
Open Access | Times Cited: 107

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Liane Dupont, Luke B. Snell, Carl Graham, et al.
Nature Microbiology (2021) Vol. 6, Iss. 11, pp. 1433-1442
Open Access | Times Cited: 106

SARS-CoV-2 infections in children: Understanding diverse outcomes
Petter Brodin
Immunity (2022) Vol. 55, Iss. 2, pp. 201-209
Open Access | Times Cited: 103

Engineered skin bacteria induce antitumor T cell responses against melanoma
Y. Erin Chen, Djenet Bousbaine, Alessandra Veinbachs, et al.
Science (2023) Vol. 380, Iss. 6641, pp. 203-210
Closed Access | Times Cited: 97

SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 87

Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
Milena Wiech, Piotr Chrościcki, Julian Swatler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84

Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 71

SARS-CoV-2 restructures host chromatin architecture
Ruoyu Wang, Joo‐Hyung Lee, Jieun Kim, et al.
Nature Microbiology (2023) Vol. 8, Iss. 4, pp. 679-694
Open Access | Times Cited: 63

Guillain–Barré syndrome associated with COVID-19: A systematic review
Vitória Pimentel, V. W. Luchsinger, Gabriel Leal Carvalho, et al.
Brain Behavior & Immunity - Health (2023) Vol. 28, pp. 100578-100578
Open Access | Times Cited: 43

Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome
Suguru Saito, Shima Shahbaz, Xian Wu Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 33

Page 1 - Next Page

Scroll to top